The largest database of trusted experimental protocols

Anti cd4 rpa t4

Manufactured by BD
Sourced in United States, France, Canada

Anti-CD4 (RPA-T4) is a mouse monoclonal antibody that recognizes the CD4 cell-surface antigen. CD4 is a glycoprotein expressed on the surface of T helper cells, monocytes, macrophages, and dendritic cells. The antibody can be used for the identification and enumeration of CD4+ cells in flow cytometric analysis.

Automatically generated - may contain errors

7 protocols using anti cd4 rpa t4

1

Lymphocyte Characterization and Cytokine Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes were identified by forward and side scatter, and cell identity was assessed using fluorochrome-conjugated antibodies anti-CD3 (clone SK7; eBioscience), anti-CD4+ (RPA-T4; BD), anti-CD8 (RPA-T8; BD), anti-CD161 (DX12; BD), and anti-TCR Vα7.2 (3C10, BioLegend). Viable cells were gated using Live/Dead Yellow or Live/Dead Aqua viability dyes (Invitrogen) according to the manufacturer’s instructions. Cells were stained for 20 minutes in the dark at room temperature, washed, and fixed in PBS containing 2% formaldehyde. All samples were acquired on LSRII or LSRFortessa flow cytometers (BD). Cell division was assessed by labeling PBMCs with 5(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes) for 10 minutes at 37°C. Staining was quenched by the addition of FBS for 5 minutes on ice. Cells were then washed and cultured as described.
For detection of intracellular cytokines, cells were stimulated with 50ng/mL soluble anti-CD3 (HIT3a; BD) and 3μg/mL soluble anti-CD28 (CD28.2; BD) for 24 hours at 37°C and 5% CO2, in the presence of brefeldin A (GolgiPlug; BD) for the final 6 hours of stimulation. After stimulation, cells were washed, stained with viability dye and antibodies to surface antigens, then fixed and permeabilized using the Cytofix/Cytoperm kit (BD) and stained intracellularly with fluorochrome-conjugated antibody to IFNγ (B27, BD).
+ Open protocol
+ Expand
2

Flow Cytometry Analysis of PBMC Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total PBMCs were cultured with or without CTHs (final concentration 10 μg/ml) in RPMI 1640 for 6h or 10h with 1X Brefeldin A (eBioscience, San Diego, CA, USA) added during the last 4 h. Stimulated cells were collected in cold FACS buffer (PBS supplemented with 2% FCS and 2 mM EDTA) and unspecific binding was blocked with 10% mouse serum. Surface stain was done with the following antibodies; anti-CD19 (HIB19), anti-CD16 (3G8) (BioLegend, San Diego, CA, USA), anti-CD4 (RPAT4) (BD Biosciences, Franklin Lakes, NJ, USA), CD3 (UCHT1), anti-CD8 (RPAT8), anti-CD14 (61D3) and anti-CD56 (CMSSB) (eBioscience, San Diego, CA, USA) conjugated to allophycocyanin-Cy7, FITC, Alexa700, eFluor450, PE-Cy7, allophycocyanin or biotin revealed by streptavidin-PECF594 (BD Biosciences, Franklin Lakes, NJ, USA). Dead cells were excluded with Live/Dead fixable aqua dead cell stain kit (Life Technologies). Intracellular staining was done with the FoxP3 Fixation/Permeabilization kit (eBioscience, San Diego, CA, USA) using anti-IP10 (J034D6) conjugated to PE (BioLegend). Data were collected using a LSRII (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed with the FlowJo software (Tree star, Ashland, OR, USA).
+ Open protocol
+ Expand
3

PBMC and CSF Cell Activation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated PBMCs and CSF cells were activated for six hours with PMA (50 ng/mL, Sigma-Aldrich), ionomycin (500 ng/mL, Sigma-Aldrich), and Golgiplug (BD Biosciences, Paris, France) before flow cytometric analysis. Cells were immunostained by surface antibody anti-CD19 (HIB19) and anti-CD4 (RPA-T4) conjugated respectively with Fluorescein isothiocyanate (FITC) and Allophycocyanin (APC) (BD Biosciences, Paris, France). Cells were fixed and permeabilized according to Cytofix/Cytoperm™ Kit protocol (BD Biosciences, Paris, France). Intracellular Phycoerythrin (PE) conjugated anti-IL-10 antibody (JES3-9D7) was added to cell suspension for 1 h in dark at +4 °C (BD Biosciences, Paris, France). Data were analyzed using the FlowJo software (version 7.6).
+ Open protocol
+ Expand
4

Characterization of WNV-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA-A*02 restricted Env430–438 (SVGGVFTSV), DRB1*01:01 restricted NS1205–220 (RLNDTWKLERAVLGEVK) or DRB1*04:01 restrictedNS1205–220 (RLNDTWKLERAVLGEVK) tetramers were described previously (James et al., 2016 (link); Piazza et al., 2010 (link)) and obtained from the NIH tetramer core facility (Atlanta, GA). PBMC from individuals who acquired WNV infection previously were incubated with indicated tetramers for 1 hour at room temperature. Cells were then washed and stained with fluorochrome-conjugated surface antibodies including anti-CD3 (HIT3a; BD Biosciences), anti-CD4 (RPA-T4; BD Biosciences), anti-CD8 (RPA-T8; BD Biosciences), anti-CCR7 (G043H7; BD Biosciences), anti-CD45RA (HI100; BD Biosciences) and LIVE/DEAD Fixable Aqua (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

Characterization of WNV-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA-A*02 restricted Env430–438 (SVGGVFTSV), DRB1*01:01 restricted NS1205–220 (RLNDTWKLERAVLGEVK) or DRB1*04:01 restrictedNS1205–220 (RLNDTWKLERAVLGEVK) tetramers were described previously (James et al., 2016 (link); Piazza et al., 2010 (link)) and obtained from the NIH tetramer core facility (Atlanta, GA). PBMC from individuals who acquired WNV infection previously were incubated with indicated tetramers for 1 hour at room temperature. Cells were then washed and stained with fluorochrome-conjugated surface antibodies including anti-CD3 (HIT3a; BD Biosciences), anti-CD4 (RPA-T4; BD Biosciences), anti-CD8 (RPA-T8; BD Biosciences), anti-CCR7 (G043H7; BD Biosciences), anti-CD45RA (HI100; BD Biosciences) and LIVE/DEAD Fixable Aqua (Thermo Fisher Scientific).
+ Open protocol
+ Expand
6

Quantifying IL-31 in HIV Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
The peripheral blood samples were collected from HIV-infected patients and mixed with EDTA to prevent coagulation. The whole blood samples were then subjected to evaluation of the CD4+ T cell count using the BD FACS Calibur platform (BD Biosciences, San Jose, CA) with anti-CD4 (RPA-T4, BD Biosciences). The serum levels of IL-31 were determined using the human IL-31 Platinum ELISA kit (E-EL-H5469c, Elabscience, China) strictly in accordance with the manufacturer's instructions. The double antibody sandwich method was used for the accurate determination of the cytokine concentration. The absorbance values at 450 nm were determined, and a standard curve was plotted to obtain the cytokine concentration in the test samples.
+ Open protocol
+ Expand
7

Multiparametric Flow Cytometry Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated using Ficoll-Paque density gradient centrifugation, frozen in freezing medium [10% DMSO, 90% fetal bovine serum (FBS)] and stored at -80°C until use. For staining, PBMCs were thawed using complete RPMI (RPMI+10%FBS) and washed with PBS. The cells were first stained using Fixable Aqua Dead Cell Kit (Thermofisher), followed by staining with anti-CD3 (UCHT1) (Biolegend), anti-CD4 (RPA-T4) (BD Biosciences), anti-CD8 (SK1) (Biolegend), anti-CD19 (HIB19) (BD Biosciences), anti-CD27 (O323) (Biolegend), anti-CD56 (B159) (BD Biosciences), anti-CD45RA (2H4) (Beckman Coulter), anti-CD38 (HIT2) (BD Biosciences) and anti-CD38 (JK36) (Beckman Coulter). The cells were washed and analyzed using BD LSRFortessa™ cell analyzer. Data analyses were performed using Flowjo V10.5.3 (BD)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!